When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 16 Mar 2025
Last updated: 21 Nov 2024

Summary

Definition

History and exam

Key diagnostic factors

  • watery discharge
  • ropy, mucoid discharge
  • purulent discharge
  • itching predominant symptom
  • red eye
  • eyelids stuck together in morning
  • tender, preauricular lymphadenopathy

Other diagnostic factors

  • conjunctival follicles
  • chemosis
  • swollen eyelids
  • superficial punctate keratopathy
  • unilateral symptoms and signs
  • use of medications that may lead to eye irritation
  • contact lens use
  • corneal subepithelial infiltrates
  • corneal pannus
  • vesicular skin rash
  • symptoms and signs of related systemic disease

Risk factors

  • exposure to infected person
  • infection in one eye
  • environmental irritants
  • allergen exposure
  • concurrent infection
  • camps, swimming pools, military bases
  • hot, dry climate
  • atopic dermatitis
  • contact lens use
  • ocular prosthesis
  • trauma: mechanical, chemical, or ultraviolet
  • recent surgery or exposed sutures
  • rosacea
  • allogeneic stem cell transplantation
  • Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN)
  • prior infection with herpes simplex virus
  • in neonate: vaginal delivery
  • oculogenital spread
  • asthma
  • hay fever
  • use of topical eye medications
  • use of oral antihistamine or anticholinergic drugs
  • neoplasia
  • history of rheumatologic disease
  • dysthyroid states
  • immunocompromised state
  • vasculitis
  • nasolacrimal duct obstruction
  • abnormality of supporting structures of the eye (adnexa)
  • severe tear deficiency
  • trauma
  • use of biologic agents

Diagnostic tests

1st tests to order

  • rapid adenovirus immunoassay

Tests to consider

  • cell culture
  • special stains (Gram, Giemsa)
  • polymerase chain reaction
  • ocular pH
  • allergy skin testing
  • tear immunoglobulin E level

Treatment algorithm

Contributors

Authors

Robert Sambursky, MD

Fellowship-Trained Ophthalmologist

Manatee Sarasota Eye Clinic & Laser Center

Bradenton

FL

Disclosures

RS is employed by Verséa Ophthalmics and serves on the board of Visus Therapeutics.

Acknowledgements

Dr Robert Sambursky would like to gratefully acknowledge Dr Lee Raykovicz, a previous contributor to this topic.

Disclosures

LR declared he was Director of Clinical Relations, Rapid Pathogen Screening, Inc.

Peer reviewers

Michael Ehrenhaus, MD

Director

Cornea, External Disease & Refractive Surgery

Long Island College Hospital Eye Center

Assistant Professor of Ophthalmology

SUNY Downstate Medical Center

Brooklyn

NY

Disclosures

ME declares that he has no competing interests.

Scott Fraser, MD, FRCS (Ed), FRCOphth

Consultant Ophthalmologist

Sunderland Eye Infirmary

Sunderland

UK

Disclosures

SF declares that he has no competing interests.

Use of this content is subject to our disclaimer